NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company focused on developing ...
HIV-positive status may be associated with increased risks for complications and poor postoperative total joint arthroplasty ...
Barclays 28th Annual Global Healthcare Conference March 11, 2026 12:00 PM EDTCompany ParticipantsAndrew Peters - Senior Vice ...
Durable 76% complete response (CR) rate at 12 months with 95% CR rate at any time in high-risk NMIBCBCG-unresponsive patients achieved an 80% CR ...
Scleral buckle repair for rhegmatogenous retinal detachment yields favorable visual outcomes in young adults, a study shows.
Rocket Pharmaceuticals, Inc. ( RCKT) TD Cowen 46th Annual Health Care Conference March 2, 2026 11:10 AM EST ...
Objective Biologics for systemic lupus erythematosus (SLE) demonstrate variable treatment responses across trials. We evaluated baseline biomarkers as predictors of response to guide personalised ...
Introduction Total alloplastic replacement of the temporomandibular joint (TMJ) is a viable treatment option for severe TMJ disorders (TMDs) unresponsive to conservative approaches, as well as for ...
Background Pharmacotherapy combinations have been shown to improve survival and reduce hospitalisations in adults with ...
Introduction The PRECISE study demonstrated that the Prospective multicentre imaging study for evaluation of chest pain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results